1.The mechanism of chitosan hemostasis and its application
Jian YANG ; Feng TIAN ; Shiqian CHEN
International Journal of Biomedical Engineering 2001;24(2):77-80
Chitosan have applied extensively in the field of medicine. We review the mechanism of chitosan hemostasis. The effect of chitosan on hemostasis is independent of all known“Cascade-like”coagulation pathways,induding platelets and soluble coagulant factors. Chitosan induce hemostasis by coalesce erythrocytes to one another to form a blood clot. In addition,the use of chitosan in hemostat is indicated in this paper.
2.Research on the hemostasis effect of chitos an's structure
Jian YANG ; Feng TIAN ; Shiqian CHEN
Chinese Medical Equipment Journal 2003;0(S1):-
The effects of chitosan and N,O-carboxymethyl chitosan on blood hemostasis are tested.The dynamic blood coagulation experiments show chitsan with low deacetylation degree has higher absorption ability.The experiments can't find that any altered red blood cell morphology or an unusual affinity between erythrocytes appears evidently in the ACD blood treated with chitosan.The concentration of the platelets on the chitosan surface may be one of causes that platelets produce blood coagulation.Chitosan is substituted by the carboxymethyl and has water solubility.But N,O-carboxymethyl chitosan can lead torouleau and not toaltering the morphology of the erythrocyte.The blood hemostasis effect is not obvious.The values of TT,PT,APTT and FIB are measured from blood and the results fail toprove that chitosan and N,O-carboxymethyl chitosan can activate the coagulation factors.
3."Reverse Immunology" and The Discovery of Immune-related Functional Genes
Chen FENG ; Jian ZHANG ; Zhigang TIAN
Progress in Biochemistry and Biophysics 2006;0(06):-
The completion of sequencing human genome creates a new era of biological science and technology. Although the sequence of the human genome has been known, it is still hard to rapidly explore the whole functional genes, especially, their interaction with each other and the meaning to the body. However, the "reverse biology" which comes into being in the recent years provides us a series of novel ideas and technologies for discovering new functional gene, among which the immune-related genes have attracted more attentions, clarifying how functional gene works and their potential value in application.
4.Effect of music and mood relaxation training for anxiety reduction in patients with breast tumor before operation
Yuewu ZHANG ; Qing CHEN ; Feng TIAN
Cancer Research and Clinic 2010;22(10):692-694
Objective To evaluate the effect of music and mood relaxation training for the anxiety in patients with breast tumor before operation. Methods With case-contrast method, 108 patients with breast tumor (52 patients with intervention, 56 with routine treatment) week assessed continuously. All cases were investigated on their common information, physiological indexes and psychological scales, including State-Trait Anxiety Inventory (STAI-Form Y), Social Support Rating Scale (SSRS) and Eysenck Personality Questionaire (EPQ). Results There were significant statistical difference in systolic pressure and pulse rate between two groups on one day (t =3.114, P <0.01) and 30-60 minutes (t =3.03, P=0.01) before the operation. There was remarkable difference for anxiety between two groups and among different interventions periods by Repeated Measures ANOVA analysis (Periods: F=18.61, P <0.01; Groups: F =7.001, P <0.05). Results of Stepwise regression analysis: The influencing factors on anxiety in patients with breast tumor before operation were trait anxiety, breast-feeding history, family history of breast tumor, age, economy and EPQ-N. Conclusion Relaxation music and mood relaxation training can reduce the level of anxiety and related physiological indexes on patients with breast tumor before operation. The influencing factors on anxiety in patients with breast tumor before operation are multi level factors, such as trait anxiety, breast-feeding history and so on.
5.Clinical observation on sirolimus-eluting stent implantation in left main coronary artery bifurcation lesions
Xiantao SONG ; Yundai CHEN ; Shuzheng LV ; Fei YUAN ; Zening JIN ; Rui TIAN ; Xin CHEN ; Feng TIAN
Chinese Journal of Postgraduates of Medicine 2006;0(19):-
Objective To evaluate the acute and long-term results of stenting for left main coronary artery (LMCA) bifurcation lesions. Methods Forty consecutive patients with LMCA bifurcation lesion and normal left ventricular function were included. Sirolimus-eluting stents were performed in all patients. Results (1)The average diameter of LMCA was (0.81?0.48)mm before stenting and increased to (3.53?0.22)mm after stenting.(2)The procedural success rate was 100.0%. In-hospital events including stent thrombosis,Q-wave myocardial infarction,and emergency bypass surgery did not occur in any patients,and non-Q-wave MI in one patient (2.5%).(3)Clinical follow-up was obtained in all patients at (8.43?3.24) months. There were no death and no myocardial infarction during follow-up. The major adverse cardis events rate was 20.0%.(4)The angiographic follow-up rate was 67.5% (27 of the 40 eligible patients),and the restenosis rate was 18.5% (parent vessel only 11.1%,side branch only 3.7%,and both 3.7%).(5)Different type of operation had no influence on restenosis rate during angiographic follow-up. Conclusion Sirolimus-eluting stent implantation for LMCA bifurcation stenosis appears safe and effective with regard to acute and midterm complications.
6.Clinical report of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity in Zone Ⅰ
Feng, CHEN ; Dao-Man, XIANG ; Jian-Xun, WANG ; Tian, LIU
International Eye Science 2016;16(7):1363-1365
AIM: To investigate the clinical effects of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity (ROP) in Zone Ⅰ.
METHODS:A retrospective study. Totally 26 ROP infants between September 2013 and October 2014 diagnosed as high - risk ROP in Zone Ⅰ had been treated with intravitreal bevacizumab. They were divided into three groups, pre - threshold ROP, threshold ROP and acute posterior ROP ( APROP ). Postoperative effects were compared.
RESULTS:There were 26 infants (52 eyes) diagnosed as ROP in Zone Ⅰ, including 3 infants( 6 eyes) with pre -threshold ROP, 15 infants (30 eyes) with threshold ROP and 8 infants (16 eyes) with APROP. The first operation recovery rate of three groups respectively were 100% (6 /6), 60% ( 18 / 30 ) and 75% ( 12 / 16 ), which were not significantly different (P>0. 05).
CONCLUSION:Intravitreal bevacizumab for ROP in ZoneⅠ seems effective and has some advantages over conventional laser treatment, which could be first line treatment for high-risk ROP in Zone Ⅰ.
7.Expression of cytokines Th1 and Th2 in patients with esophageal squamous cell carcinoma.
Peng-Cheng CHEN ; Jian-Guo FENG ; Yu-Tian LING
Chinese Journal of Oncology 2007;29(11):850-851
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Squamous Cell
;
immunology
;
pathology
;
Cytokines
;
blood
;
Esophageal Neoplasms
;
immunology
;
pathology
;
Female
;
Humans
;
Interferon-gamma
;
blood
;
Interleukin-10
;
blood
;
Interleukin-12
;
blood
;
Interleukin-4
;
blood
;
Interleukin-5
;
blood
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Th1 Cells
;
immunology
;
Th2 Cells
;
immunology
;
Tumor Necrosis Factor-alpha
;
blood
9.The effect of recombinant human tissue factor pathway inhibitor-1 on Myocardial infarction in rabbits
Jingguang LUO ; Yundai CHEN ; Yuan Lü ; Feng TIAN ; Changhua WANG
Chinese Journal of Emergency Medicine 2011;20(5):507-510
Objective To observe the function of recombinant human tissue factor pathway inhibitor1(rTFPI-1)in acute myocardial infarction in rabbit. Method Forty New Zealand White rabbits were subjected to coronary artery occlusion for 120 min and followed by reperfusion for 60 min,then they were ranlow dose rTFPI-1 group(n=10/group).The extent of ischemic area and the extent of myocardial infarction area were measured by Evan's blue stain and TTC stain,respectively.The degrees of infarction severity and ischemic severity were expressed as the ratios of the total left ventrieular wall area.The degrees of infarction severity and ischemic severity in different groups were compared by using one-way ANOVA and then followed by LSD procedure.Results The degree of infarction severity in the larger dose rTFPI-1 group was significantly lessened than that in low dose RTFPI-1 group and control group(P<0.001),and than that in modcrate dose rTFPI-1 group as well(P<0.05).The degree of infarction severity in the moderate dose rTFPI1 group was significantly lessened than that in low dose rTFPI-1 group and control group(P<0.001).There was no significant difference in degree of infarction severity between low dose rTFPI-1 group and control group(P>0.05).Conclusions Human rTFPI-1 might decrease myocardial infarction severity and save the survival myocardial tissue.
10.Effect of 89SrCl2 for bone metastasis in Uygur and Han patients with prostate cancer
Ximei FENG ; Shuli GUO ; Yongfang TIAN ; Cheng CHEN ; Hongli WANG
Cancer Research and Clinic 2015;27(8):532-534
Objective To analyze contrastly the effect of 89SrCl2 for bone metastasis in Uygur and Han patients with prostate cancer.Methods The curative effects in 75 Uygur and 82 Han patients with prostate cancer bone metastasis were investigated after intravenous injection with 89SrCl2,including palliation of pain.SPECT was used to detect the change of metastasis,level of prostate-specific antigen (PSA) and interleukin-6 (IL-6) were detected by electrochemiluminescence immunoassay.Results After treated with 89SrCl2,the palliation rate,the bone metastases and the level of IL-6 were higher in Uygur patients [82.67 % (62/75),75 % (56/75),(4.24±1.74) pg/ml] than those in Han patients [60.98 % (50/82),52.44 % (43/82),(2.81±2.38) pg/ml],and there were statistically significant (P < 0.05).Conclusion 89SrCl2 is more effective for the Uygur patients with prostate cancer bone metastasis than the Han patients,clinical workers should pay more attention to this.